Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
United Therapeutics history
United Therapeutics company history timeline
In 2002, the United States Food and Drug Administration (FDA) approved United Therapeutics' drug Remodulin, a prostacyclin vasodilator used to treat PAH. Remodulin provided PAH patients an alternative to GlaxoSmithKline's Flolan.
In 2011, United Therapeutics acquired Revivicor, a company focused on developing genetic biotechnology platforms to provide alternative tissue sources for treatment.
In 2018, the company acquired SteadyMed, a medical device company developing injectable therapeutic drugs for pulmonary hypertension.
In March 2021, United Therapeutics’ market capitalization was $7.1 billion.
In 2022, a porcine heart provided by Revivicor was used in the first pig-to-human transplant operation.
Rate United Therapeutics' efforts to communicate its history to employees.
United Therapeutics jobs
Do you work at United Therapeutics?
Is United Therapeutics' vision a big part of strategic planning?
United Therapeutics competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Gilead Sciences | 1987 | $28.8B | 11,800 | 734 |
| Regeneron | 1988 | $14.2B | 9,123 | 343 |
| Vertex Pharmaceuticals | 1989 | $11.0B | 3,400 | 130 |
| Moderna | 2010 | $3.2B | 2,500 | 83 |
| Neurocrine Biosciences | 1992 | $2.4B | 400 | 380 |
| Merck | 1891 | $64.2B | 74,000 | 1,711 |
| Johnson & Johnson | 1886 | $88.8B | 134,500 | 1,707 |
| Medivation | 2003 | $1.0B | 628 | - |
| Alnylam Pharmaceuticals | 2002 | $2.2B | 1,323 | - |
| Medicomp | 1981 | $21.0M | 150 | - |
United Therapeutics history FAQs
Zippia gives an in-depth look into the details of United Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about United Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at United Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by United Therapeutics. The data presented on this page does not represent the view of United Therapeutics and its employees or that of Zippia.
United Therapeutics may also be known as or be related to UNITED THERAPEUTICS CORP, United Therapeutics, United Therapeutics Corp. and United Therapeutics Corporation.